IGFBP2 and prediabetes syndrome: These results point to a role of CYP7B1 in the control of hepatic IGFBP2 and VLDL-TG without changes in a glucose oral tolerance test, suggesting a prediabetes state exerted through different hydroxycholesterol metabolites and transcriptional or translational mechanisms depending on the species.